What is nitroglycerin used for? Nitroglycerin is commonly used to treat and prevent chest pain caused by a type of heart disease (coronary artery disease). Nitroglycerin may also be used for other ...

GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...

GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced the commercial availability of GONITRO™ (nitroglycerin) sublingual ...

THE value of sublingual administration of nitroglycerin for relief of attacks of angina pectoris is well established. Nitroglycerin has also been advocated as a prophylactic — before exercise and so ...

ALLEGAN (WWJ) --Perrigo Co. (NYSE: PRGO) announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent ...

The U.S. Food and Drug Administration has approved First Horizon Pharmaceutical Corp.'s 60-dose configuration of its sublingual nitroglycerin spray, Nitrolingual Pumpspray. The currently approved ...

CHEST discomfort associated with paroxysmal nocturnal dyspnea is frequently quite distressing, and some patients describe this discomfort as pain. 1 During the past several years, we have noted in the ...

Accordingly to New York Times journalist Natasha Singer, approximately four million prescriptions for nitroglycerin were written in the US in 2009 [1]. The American HeartAssociation statistics show ...

Perrigo Company PRGO today announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent to ...